A continuous-flow left ventricular assist device (LVAD) improved survival free from disabling stroke compared with a pulsatile LVAD, when used as destination therapy over a 2-year period in patients ...

LOUISVILLE, Ky. – A new generation of implanted devices that help a failing heart function properly is significantly more effective than the previous version, making these new devices an appropriate ...

Nat Clin Pract Cardiovasc Med. 2006;3(7):377-386. Special silicone cannulae connect the blood pumps to the body (Figure 2). These cannulae are anastomosed to the right atrium and pulmonary artery for ...

This section describes efficacy outcomes from the published literature that the Committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see ...

Researchers from the University of South Florida developed a novel ventricular assist device that is placed directly inside a failing ventricular cavity to help it pump blood correctly again. This ...

April 18, 2011 (San Diego, California) — Nearly 50% of patients receiving a left ventricular assist device (LVAD) experience a hospital readmission within 6 months of implantation, and most first-time ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...